歐洲整形外科用生物材料市場動向：2007年

Abstract

The European orthopedic biomaterials market was valued at over $200 million in 2006.

This market is comprised of France, Germany, Austria, Italy, Spain, and the UK.

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET

• 1.1 Market Overview
• 1.2 Market Analysis
  • 1.2.1 Market Forecast
• 1.3 Competitive Analysis

2.0 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

• 2.1 Market Overview
• 2.2 Osteoarthritis Overview
  • 2.2.1 Causal Factors
  • 2.2.2 Treatment Alternatives to Hyaluronic Acid Viscosupplementation
• 2.3 Hyaluronic Acid Viscosupplementation Overview
• 2.4 Market Analysis
  • 2.4.1 Procedures
    • 2.4.1.1 Austrian HA Viscosupplementation Procedures
    • 2.4.1.2 French HA Viscosupplementation Procedures
    • 2.4.1.3 German HA Viscosupplementation Procedures
    • 2.4.1.4 Italian HA Viscosupplementation Procedures
    • 2.4.1.5 Spanish HA Viscosupplementation Procedures
    • 2.4.1.6 UK HA Viscosupplementation Procedures
  • 2.4.2 Market Forecast
    • 2.4.2.1 Austrian HA Viscosupplementation Market Forecast
    • 2.4.2.2 French HA Viscosupplementation Market Forecast
    • 2.4.2.3 German HA Viscosupplementation Market Forecast
    • 2.4.2.4 Italian HA Viscosupplementation Market Forecast
    • 2.4.2.5 Spanish HA Viscosupplementation Market Forecast
    • 2.4.2.6 UK HA Viscosupplementation Market Forecast
  • 2.4.3 Market Drivers and Limiters
    • 2.4.3.1 Market Drivers
    • 2.4.3.2 Market Limiters
• 2.5 Competitive Analysis

3.0 BONE GRAFT SUBSTITUTE MARKET

• 3.1 Market Overview
• 3.2 Bone Graft Substitute Overview
  • 3.2.1 Autograft
  • 3.2.2 Allograft
  • 3.2.3 Xenograft
  • 3.2.4 Demineralized Bone Matrix
  • 3.2.5 Synthetic Bone
  • 3.2.6 Growth Factors
• 3.3 Market Analysis
  • 3.3.1 Procedures
    • 3.3.1.1 Segmented by Material
    • 3.3.1.2 Segmented by Indication
    • 3.3.1.3 French Bone Graft Procedures
    • 3.3.1.4 German Bone Graft Procedures
    • 3.3.1.5 Italian Bone Graft Procedures
    • 3.3.1.6 Spanish Bone Graft Procedures
    • 3.3.1.7 UK Bone Graft Procedures
  • 3.3.2 Market Forecast
    • 3.3.2.1 French Bone Graft Substitute Market Forecast
    • 3.3.2.2 German Bone Graft Substitute Market Forecast
    • 3.3.2.3 Italian Bone Graft Substitute Market Forecast
    • 3.3.2.4 Spanish Bone Graft Substitute Market Forecast
    • 3.3.2.5 UK Bone Graft Substitute Market Forecast
  • 3.3.3 Market Drivers and Limiters
    • 3.3.3.1 Market Drivers
    • 3.3.3.2 Market Limiters
• 3.4 Competitive Analysis

4.0 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

• 4.1 Market Overview
• 4.2 Autologous Chondrocyte Implantation Overview
  • 4.2.1 Osteoarticular Autografts
  • 4.2.2 Osteoarticular Allografts
  • 4.2.3 Autologous Chondrocyte Implantation
• 4.3 Market Analysis
  • 4.3.1 Procedures
  • 4.3.2 Market Forecast
    • 4.3.2.1 Austrian Autologous Chondrocyte Implantation Market Forecast
    • 4.3.2.2 French Autologous Chondrocyte Implantation Market Forecast
    • 4.3.2.3 German Autologous Chondrocyte Implantation Market Forecast
    • 4.3.2.4 Italian Autologous Chondrocyte Implantation Market Forecast
    • 4.3.2.5 Spanish Autologous Chondrocyte Implantation Market Forecast
    • 4.3.2.6 UK Autologous Chondrocyte Implantation Market Forecast
  • 4.3.3 Market Drivers and Limiters
    • 4.3.3.1 Market Drivers
    • 4.3.3.2 Market Limiters
• 4.4 Competitive Analysis

5.0 PLATELET CONCENTRATION SYSTEMS MARKET

• 5.1 Market Overview
• 5.2 Platelet Concentration Systems Overview
• 5.3 Market Analysis
  • 5.3.1 Market Forecast
  • 5.3.2 Market Drivers and Limiters
    • 5.3.2.1 Market Drivers
    • 5.3.2.2 Market Limiters
• 5.4 Competitive Analysis

APPENDIX A: MRG ACRONYMS AND INITIALISMS

List of Exhibits

EXECUTIVE SUMMARY

• Exhibit ES-1: Orthopedic Biomaterials Market, by Segment, Europe (US$), 2005-2011
• Exhibit ES-2: 1-Injection HA Viscosupplementation Treatments, Europe, 2005-2011
• Exhibit ES-3: BGS Market, by Country, Europe (US$), 2005-2011
• Exhibit ES-4: ACI Market, Italy (US$), 2005-2011
• Exhibit ES-5: PCS Market, Europe (US$), 2005-2011
• Exhibit ES-6: Leading Competitors of the European Orthopedic Biomaterial Market, 2006

METHODOLOGY

• Exhibit M-1: Currency Exchange Rates, 2006

CHAPTER 1: EUROPEAN ORTHOPEDIC BIOMATERIAL MARKET

• Exhibit 1-1: Orthopedic Biomaterials Market, by Segment, Europe (US$), 2005-2011 (Graphical Format)
• Exhibit 1-2: Orthopedic Biomaterials Market, by Segment, Europe (US$), 2005-2011 (Tabular Format)
• Exhibit 1-3: Orthopedic Biomaterials, Europe (€), 2005-2011
• Exhibit 1-4: Leading Competitors in the Orthopedic Biomaterials Market, by Segment, Europe, 2006
• Exhibit 1-5: Leading Competitors of the European Orthopedic Biomaterials Market, 2006

CHAPTER 2: HYALURONIC ACID VISCOSUPPLEMENTATION

• Exhibit 2-1: HA Viscosupplementation Market, Europe (US$), 2005-2011
• Exhibit 2-2: HA Viscosupplementation Injections and Treatments, Europe, 2006
• Exhibit 2-3: HA Viscosupplementation Injections and Treatments, Europe, 2005-2011
• Exhibit 2-4: HA Viscosupplementation Injections, by Country, Europe, 2005-2011
• Exhibit 2-5: HA Viscosupplementation Injections and Treatments, Austria, 2006
• Exhibit 2-6: HA Viscosupplementation Injections and Treatments, Austria, 2005-2011
• Exhibit 2-7: HA Viscosupplementation Injections and Treatments, France, 2006
• Exhibit 2-8: HA Viscosupplementation Injections andTreatments, France, 2005-2011
• Exhibit 2-9: HA Viscosupplementation Injections and Treatments, Germany, 2006
• Exhibit 2-10: HA Viscosupplementation Injections and Treatments, Germany, 2005-2011
• Exhibit 2-11: HA Viscosupplementation Injections and Treatments, Italy, 2006
• Exhibit 2-12: HA Viscosupplementation Injections and Treatments, Italy, 2005-2011
• Exhibit 2-13: HA Viscosupplementation Injections and Treatments, Spain, 2006
• Exhibit 2-14: HA Viscosupplementation Injections and Treatments, Spain, 2005-2011
• Exhibit 2-15: HA Viscosupplementation Injections and Treatments, UK, 2006
• Exhibit 2-16: HA Viscosupplementation Injections and Treatments, UK, 2005-2011
• Exhibit 2-17: HA Viscosupplementation Injection Market, Europe (US$), 2005-2011
• Exhibit 2-18: HA Viscosupplementation Injection Market, Europe (€), 2005-2011
• Exhibit 2-19: HA Viscosupplementation Treatment Market, Europe (US$), 2005-2011
• Exhibit 2-20: HA Viscosupplementation Treatment Market, Europe (€), 2005-2011
• Exhibit 2-21: HA Viscosupplementation Market, by Country, Europe (US$), 2005-2011
• Exhibit 2-22: HA Viscosupplementation Market, by Country, Europe (€), 2005-2011
• Exhibit 2-23: HA Viscosupplementation Injection Market, Austria (US$), 2005-2011
• Exhibit 2-24: HA Viscosupplementation Injection Market, Austria (€), 2005-2011
• Exhibit 2-25: HA Viscosupplementation Treatment Market, Austria (US$), 2005-2011
• Exhibit 2-26: HA Viscosupplementation Treatment Market, Austria (€), 2005-2011
• Exhibit 2-27: HA Viscosupplementation Injection Market, France (US$), 2005-2011
• Exhibit 2-28: HA Viscosupplementation Injection Market, France (€), 2005-2011
• Exhibit 2-29: HA Viscosupplementation Treatment Market, France (US$), 2005-2011
• Exhibit 2-30: HA Viscosupplementation Treatment Market, France (€), 2005-2011
• Exhibit 2-31: HA Viscosupplementation Injection Market, Germany (US$), 2005-2011
• Exhibit 2-32: HA Viscosupplementation Injection Market, Germany (€), 2005-2011
• Exhibit 2-33: HA Viscosupplementation Treatment Market, Germany (US$), 2005-2011
• Exhibit 2-34: HA Viscosupplementation Treatment Market, Germany (€), 2005-2011
• Exhibit 2-35: HA Viscosupplementation Injection Market, Italy (US$), 2005-2011
• Exhibit 2-36: A Viscosupplementation Injection Market, Italy (€), 2005-2011
• Exhibit 2-37: HA Viscosupplementation Treatment Market, Italy (US$), 2005-2011
• Exhibit 2-38: HA Viscosupplementation Treatment Market, Italy (€), 2005-2011
• Exhibit 2-39: HA Viscosupplementation Injection Market, Spain (US$), 2005-2011
• Exhibit 2-40: HA Viscosupplementation Injection Market, Spain (€), 2005-2011
• Exhibit 2-41: HA Viscosupplementation Treatment Market, Spain (US$), 2005-2011
• Exhibit 2-42: HA Viscosupplementation Treatment Market, Spain (€), 2005-2011
• Exhibit 2-43: HA Viscosupplementation Injection Market, UK (US$), 2005-2011
• Exhibit 2-44: HA Viscosupplementation Injection Market, UK (€), 2005-2011
• Exhibit 2-45: HA Viscosupplementation Injection Market, UK (£), 2005-2011
• Exhibit 2-46: HA Viscosupplementation Treatment Market, UK (US$), 2005-2011
• Exhibit 2-47: HA Viscosupplementation Treatment Market, UK (€), 2005-2011
• Exhibit 2-48: HA Viscosupplementation Treatment Market, UK (£), 2005-2011
• Exhibit 2-49: Drivers and Limiters of the HA Viscosupplementation Market, Europe
• Exhibit 2-50: Leading Competitors in the HA Viscosupplementation Treatment Market, by Country, Europe, 2006

CHAPTER 3: BONE GRAFT SUBSTITUTE MARKET

• Exhibit 3-1: BGS Market, by Country, Europe (US$), 2005-2011 (Graphical Format)
• Exhibit 3-2: Characteristics of BGS Materials
• Exhibit 3-3: Advantages and Disadvantages of Various BGS Materials
• Exhibit 3-4: Selected Synthetic BGS Materials
• Exhibit 3-5: Bone Graft Procedures, by Material, Europe, 2005-2011
• Exhibit 3-6: BGS Procedures, by Material, Europe, 2005-2011
• Exhibit 3-7: Bone Graft Procedures, by Indication, Europe, 2005-2011
• Exhibit 3-8: BGS Procedures, by Indication, Europe, 2005-2011
• Exhibit 3-9: BGS Procedures, by Indication, As a % of Total, Europe, 2005-2011
• Exhibit 3-10: Quantity of Bone Graft Material Used, by Indication
• Exhibit 3-11: Bone Graft Procedures, by Material, France, 2005-2011
• Exhibit 3-12: BGS Procedures, by Material, France, 2005-2011
• Exhibit 3-13: Bone Graft Procedures, by Indication, France, 2005-2011
• Exhibit 3-14: BGS Procedures, by Indication, France, 2005-2011
• Exhibit 3-15: Bone Graft Procedures, by Material, Germany, 2005-2011
• Exhibit 3-16: BGS Procedures, by Material, Germany, 2005-2011
• Exhibit 3-17: Bone Graft Procedures, by Indication, Germany, 2005-2011
• Exhibit 3-18: BGS Procedures, by Indication, Germany, 2005-2011
• Exhibit 3-19: Bone Graft Procedures, by Material, Italy, 2005-2011
• Exhibit 3-20: BGS Procedures, by Material, Italy, 2005-2011
• Exhibit 3-21: Bone Graft Procedures, by Indication, Italy, 2005-2011
• Exhibit 3-22: BGS Procedures, by Indication, Italy, 2005-2011
• Exhibit 3-23: Bone Graft Procedures, by Material, Spain, 2005-2011
• Exhibit 3-24: BGS Procedures, by Material, Spain, 2005-2011
• Exhibit 3-25: Bone Graft Procedures, by Indication, Spain, 2005-2011
• Exhibit 3-26: BGS Procedures, by Indication, Spain, 2005-2011
• Exhibit 3-27: Bone Graft Procedures, by Material, UK, 2005-2011
• Exhibit 3-28: BGS Procedures, by Material, UK, 2005-2011
• Exhibit 3-29: Bone Graft Procedures, by Indication, UK, 2005-2011
• Exhibit 3-30: BGS Procedures, by Indication, UK, 2005-2011
• Exhibit 3-31: BGS Procedural ASPs, by Indication, Europe (US$), 2005-2011
• Exhibit 3-32: BGS Procedural ASPs, by Indication, Europe (€), 2005-2011
• Exhibit 3-33: BGS Market, Europe (US$), 2005-2011
• Exhibit 3-34: BGS Market, Europe (€), 2005-2011
• Exhibit 3-35: BGS Market, by Country, Europe (US$), 2005-2011 (Tabular Format)
• Exhibit 3-36: BGS Market, by Country, Europe (€), 2005-2011
• Exhibit 3-37: BGS Market, by Country, As a % of Total, Europe, 2005-2011
• Exhibit 3-38: BGS Market, by Material, Europe (US$), 2005-2011
• Exhibit 3-39: BGS Market, by Material, Europe (€), 2005-2011
• Exhibit 3-40: BGS Market, by Indication, Europe (US$), 2005-2011
• Exhibit 3-41: BGS Market, by Indication, Europe (€), 2005-2011
• Exhibit 3-42: BGS Market, by Indication, As a % of Total, Europe, 2005-2011
• Exhibit 3-43: BGS Procedural ASPs, by Indication, France (US$), 2005-2011
• Exhibit 3-44: BGS Procedural ASPs, by Indication, France (€), 2005-2011
• Exhibit 3-45: BGS Market, France (US$), 2005-2011
• Exhibit 3-46: BGS Market, France (€), 2005-2011
• Exhibit 3-47: BGS Market, by Material, France (US$), 2005-2011
• Exhibit 3-48: BGS Market, by Material, France (€), 2005-2011
• Exhibit 3-49: BGS Market, by Indication, France (US$), 2005-2011
• Exhibit 3-50: BGS Market, by Indication, France (€), 2005-2011
• Exhibit 3-51: BGS Procedural ASPs, by Indication, Germany (US$), 2005-2011
• Exhibit 3-52: BGS Procedural ASPs, by Indication, Germany (€), 2005-2011
• Exhibit 3-53: BGS Market, Germany (US$), 2005-2011
• Exhibit 3-54: BGS Market, Germany (€), 2005-2011
• Exhibit 3-55: BGS Market, by Material, Germany (US$), 2005-2011
• Exhibit 3-56: BGS Market, by Material, Germany (€), 2005-2011
• Exhibit 3-57: BGS Market, by Indication, Germany (US$), 2005-2011
• Exhibit 3-58: BGS Market, by Indication, Germany (€), 2005-2011
• Exhibit 3-59: BGS Procedural ASPs, by Indication, Italy (US$), 2005-2011
• Exhibit 3-60: BGS Procedural ASPs, by Indication, Italy (€), 2005-2011
• Exhibit 3-61: BGS Market, Italy (US$), 2005-2011
• Exhibit 3-62: BGS Market, Italy (€), 2005-2011
• Exhibit 3-63: BGS Market, by Material, Italy (US$), 2005-2011
• Exhibit 3-64: BGS Market, by Material, Italy (€), 2005-2011
• Exhibit 3-65: BGS Market, by Indication, Italy (US$), 2005-2011
• Exhibit 3-66: BGS Market, by Indication, Italy (€), 2005-2011
• Exhibit 3-67: BGS Procedural ASPs, by Indication, Spain (US$), 2005-2011
• Exhibit 3-68: BGS Procedural ASPs, by Indication, Spain (€), 2005-2011
• Exhibit 3-69: BGS Market, Spain (US$), 2005-2011
• Exhibit 3-70: BGS Market, Spain (€), 2005-2011
• Exhibit 3-71: BGS Market, by Material, Spain (US$), 2005-2011
• Exhibit 3-72: BGS Market, by Material, Spain (€), 2005-2011
• Exhibit 3-73: BGS Market, by Indication, Spain (US$), 2005-2011
• Exhibit 3-74: BGS Market, by Indication, Spain (€), 2005-2011
• Exhibit 3-75: BGS Procedural ASPs, by Indication, UK (US$), 2005-2011
• Exhibit 3-76: BGS Procedural ASPs, by Indication, UK (€), 2005-2011
• Exhibit 3-77: BGS Procedural ASPs, by Indication, UK (£), 2005-2011
• Exhibit 3-78: BGS Market, UK (US$), 2005-2011
• Exhibit 3-79: BGS Market, UK (€), 2005-2011
• Exhibit 3-80: BGS Market, UK (£), 2005-2011
• Exhibit 3-81: BGS Market, by Material, UK (US$), 2005-2011
• Exhibit 3-82: BGS Market, by Material, UK (€), 2005-2011
• Exhibit 3-83: BGS Market, by Material, UK (£), 2005-2011
• Exhibit 3-84: BGS Market, by Indication, UK (US$), 2005-2011
• Exhibit 3-85: BGS Market, by Indication, UK (€), 2005-2011
• Exhibit 3-86: BGS Market, by Indication, UK (£), 2005-2011
• Exhibit 3-87: Drivers and Limiters of the BGS Market, Europe
• Exhibit 3-88: Leading Competitors in the BGS Market, by Country, as a % of Total, Europe, 2006

CHAPTER 4: AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

• Exhibit 4-1: ACI Market, Europe (US$), 2005-2011 (Graphical Format)
• Exhibit 4-2: ACI Procedures, by Country, Europe, 2005-2011
• Exhibit 4-3: ACI Procedure, by Country, Europe, as a % of Total, 2005-2011
• Exhibit 4-4: ACI Market, Europe (US$), 2005-2011 (Tabular Format)
• Exhibit 4-5: ACI Market, Europe (€), 2005-2011
• Exhibit 4-6: ACI Market, by Country, Europe (US$), 2005-2011
• Exhibit 4-7: ACI Market, by Country, Europe (€), 2005-2011
• Exhibit 4-8: ACI Market, by Country, as a % of Total, Europe, 2005-2011
• Exhibit 4-9: ACI Market, Austria (US$), 2005-2011
• Exhibit 4-10: ACI Market, Austria (€), 2005-2011
• Exhibit 4-11: ACI Market, France (US$), 2005-2011
• Exhibit 4-12: ACI Market, France (€), 2005-2011
• Exhibit 4-13: ACI Market, Germany (US$), 2005-2011
• Exhibit 4-14: ACI Market, Germany (€), 2005-2011
• Exhibit 4-15: ACI Market, Italy (US$), 2005-2011
• Exhibit 4-16: ACI Market, Italy (€), 2005-2011
• Exhibit 4-17: ACI Market, Spain (US$), 2005-2011
• Exhibit 4-18: ACI Market, Spain (€), 2005-2011
• Exhibit 4-19: ACI Market, UK (US$), 2005-2011
• Exhibit 4-20: ACI Market, UK (€), 2005-2011
• Exhibit 4-21: ACI Market, UK (£), 2005-2011
• Exhibit 4-22: Drivers and Limiters of the ACI Market, Europe, 2006
• Exhibit 4-23: Leading Competitors in the ACI Market, as a % of Total, Europe, 2006

CHAPTER 5: PLATELET CONCENTRATION SYSTEMS MARKET

• Exhibit 5-1: PCS Market, Europe (US$), 2005-2011(Graphical Format)
• Exhibit 5-2: PCS Market, Europe (US$), 2005-2011 (Tabular Format)
• Exhibit 5-3: PCS Market, Europe (€), 2005-2011
• Exhibit 5-4: Drivers and Limiters of the PCS market, Europe
• Exhibit 5-5: Leading Competitors in the PCS Market, as a % of Total, Europe, 2006